Meeting of the Advisory Committee on Immunization Practices (ACIP), 58478 [2015-24656]
Download as PDF
<![CDATA[
58478
Federal Register / Vol. 80, No. 188 / Tuesday, September 29, 2015 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Meeting of the Advisory Committee on
Immunization Practices (ACIP)
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
PAR14–227, Workers’ Compensation
Surveillance.
8:00 a.m.–7:00 p.m.,
EST, November 3–5, 2015 (Closed).
TIME AND DATE:
Internet Assisted Meeting (IAM)/
Virtual Meeting.
PLACE:
The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
STATUS:
The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Workers’ Compensation Surveillance,
PAR14–227, initial review.’’
MATTERS FOR DISCUSSION:
CONTACT PERSON FOR MORE INFORMATION:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Donald Blackman, Ph.D., Scientific
Review Officer, CDC, 2400 Century
Center Parkway, NE., 4th Floor, Room
4204, Mailstop E–74, Atlanta, Georgia
30345, Telephone: (404) 498–6185,
DYB7@CDC.GOV .
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2015–24658 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:54 Sep 28, 2015
Jkt 235001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee.
TIME AND DATE: 8:00 a.m.–6:00 p.m.,
EDT, October 21, 2015.
PLACE: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30329.
STATUS: Open to the public, limited
only by the space available. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt
October 12, 2015. All requests must
contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length
and delivered in 3 minutes or less.
Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
The meeting will be webcast live via
the World Wide Web; for instructions
and more information on ACIP please
visit the ACIP Web site: https://
www.cdc.gov/vaccines/acip/.
PURPOSE: The committee is charged
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines. Further, under provisions of
the Affordable Care Act, at section 2713
of the Public Health Service Act,
immunization recommendations of the
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
ACIP that have been adopted by the
Director of the Centers for Disease
Control and Prevention and appear on
the CDC immunization schedules must
be covered by applicable health plans.
MATTERS FOR DISCUSSION: The agenda
will include discussions on: child and
adolescent immunization schedule;
adult immunization schedule;
meningococcal vaccines; human
papillomavirus vaccines; influenza;
combination vaccine (pediatric
hexavalent vaccine (DTaP–IPV-HibHepB); cholera vaccine; Japanese
encephalitis vaccine; Ebola vaccine trial
update and vaccine supply.
Recommendation votes are scheduled
for child and adolescent immunization
schedule and adult immunization
schedule.
Agenda items are subject to change as
priorities dictate.
CONTACT PERSON FOR MORE INFORMATION:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2015–24656 Filed 9–28–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
TIME AND DATE: 8:30 a.m.–4:00 p.m. EDT,
October 21, 2015.
PLACE: CDC, Building 19, Rooms 254/
255, 1600 Clifton Road NE., Atlanta,
Georgia 30333.
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 80, Number 188 (Tuesday, September 29, 2015)]
[Notices]
[Page 58478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24656]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Committee on Immunization Practices
(ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee.
Time and Date: 8:00 a.m.-6:00 p.m., EDT, October 21, 2015.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton Road
NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited only by the space available. Time
will be available for public comment. The public is welcome to submit
written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt October 12, 2015. All requests must contain the
name, address, and organizational affiliation of the speaker, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length and delivered in 3 minutes or less.
Please note that the public comment period may end before the time
indicated, following the last call for comments. Members of the public
who wish to provide public comments should plan to attend the public
comment session at the start time listed. Written comments received in
advance of the meeting will be included in the official record of the
meeting.
The meeting will be webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: https://www.cdc.gov/vaccines/acip/.
Purpose: The committee is charged with advising the Director, CDC, on
the appropriate use of immunizing agents. In addition, under 42 U.S.C.
1396s, the committee is mandated to establish and periodically review
and, as appropriate, revise the list of vaccines for administration to
vaccine-eligible children through the Vaccines for Children (VFC)
program, along with schedules regarding the appropriate periodicity,
dosage, and contraindications applicable to the vaccines. Further,
under provisions of the Affordable Care Act, at section 2713 of the
Public Health Service Act, immunization recommendations of the ACIP
that have been adopted by the Director of the Centers for Disease
Control and Prevention and appear on the CDC immunization schedules
must be covered by applicable health plans.
Matters For Discussion: The agenda will include discussions on: child
and adolescent immunization schedule; adult immunization schedule;
meningococcal vaccines; human papillomavirus vaccines; influenza;
combination vaccine (pediatric hexavalent vaccine (DTaP-IPV-Hib-HepB);
cholera vaccine; Japanese encephalitis vaccine; Ebola vaccine trial
update and vaccine supply. Recommendation votes are scheduled for child
and adolescent immunization schedule and adult immunization schedule.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Stephanie Thomas, National Center
for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road NE.,
MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; Email
ACIP@CDC.GOV.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2015-24656 Filed 9-28-15; 8:45 am]
BILLING CODE 4163-18-P
